Loading video...

Video Failed to Load

There was a problem loading this video. This could be due to a temporary network issue or the video might be unavailable.

NIH researchers are exploring how immature cells called stem cells develop into specialized cells like heart or lung cells. This research on how cells keep their DNA organized during that specialization process could help advance the development of lab grown organs for thousands of people waiting on a transplant.... show more

NIH

1,741,619 subscribers

19,895 views • 6 months ago •via X (Twitter)

Anya Rossi• Live Now

Private livecam show

0 Comments

No comments available

Comments from the original post will appear here

Related Videos

What if scientists knew how to stop or slow the spread of cancer cells to other parts of the body? This process, also known as cancer metastasis, is responsible for the majority of cancer deaths. NIH researchers are studying this process with hopes of preventing it from happening. 🎥 Watch the full video to learn more:

What if scientists knew how to stop or slow the spread of cancer cells to other parts of the body? This process, also known as cancer metastasis, is responsible for the majority of cancer deaths. NIH researchers are studying this process with hopes of preventing it from happening. 🎥 Watch the full video to learn more:

NIH

12,677 views • 2 months ago

Another timelapse view into our beloved International Space Station Lifesciences Glovebox – this time to harvest the stem cells and conclude the experiment (May 28 post). This goal of this experiment was to produce stem cells in large numbers, using the innovative microgravity bioreactor seen inside the glovebox. Stem cell therapies provide significant benefits to help patients fight disease or recover from chemotherapy. The scientists behind this experiment hypothesized that space-grown cells may retain the ability to continuously divide for longer than stem cells on Earth, which could create larger supplies of cells crucial to provide therapies for patients back on Earth. Stay tuned, because the initial results appear incredibly promising!

Another timelapse view into our beloved International Space Station Lifesciences Glovebox – this time to harvest the stem cells and conclude the experiment (May 28 post). This goal of this experiment was to produce stem cells in large numbers, using the innovative microgravity bioreactor seen inside the glovebox. Stem cell therapies provide significant benefits to help patients fight disease or recover from chemotherapy. The scientists behind this experiment hypothesized that space-grown cells may retain the ability to continuously divide for longer than stem cells on Earth, which could create larger supplies of cells crucial to provide therapies for patients back on Earth. Stay tuned, because the initial results appear incredibly promising!

Jessica Meir

16,643 views • 2 months ago

It’s pretty rare to find a typo in a book thanks to the work of eagle-eyed editors. Check out the latest NIH Intramural SciBites video to learn about NIH graduate student Darren Boydston's investigations into how our cells edit the messenger RNA molecules that help turn DNA’s genetic instructions into hard-working proteins:

It’s pretty rare to find a typo in a book thanks to the work of eagle-eyed editors. Check out the latest NIH Intramural SciBites video to learn about NIH graduate student Darren Boydston's investigations into how our cells edit the messenger RNA molecules that help turn DNA’s genetic instructions into hard-working proteins:

NIH

17,206 views • 1 year ago

New Research Deep Dive: The "Shedding" Conversation Just Got More Serious A new in-vitro study (using human cells in a lab) on the Pfizer mRNA vaccine has revealed critical findings that can no longer be ignored. Let's break it down. The researchers confirmed two major things: 1️⃣ Spike Protein Production: The cells successfully took up the mRNA and began producing the SARS-CoV-2 spike protein, displaying it on their surface. This was expected. 2️⃣ Spike Protein "Shedding" via Exosomes: Here's the crucial part. The cells didn't just keep the spike protein to themselves. They packaged it into exosomes—tiny extracellular vesicles cells use to communicate—and excreted them into the environment. Why does this matter? This provides a potential mechanistic blueprint for how spike protein could travel systemically throughout the body after vaccination. These spike-laden exosomes can enter the bloodstream and, theoretically, deliver their cargo to distant organs and other cells. But the most alarming part? The authors note a profound lack of safety data. They explicitly state: We have no scientific studies to determine if this exosome-mediated spread of spike protein is toxic to other human cells. Even more concerning, they observed "pathological changes" and toxicity within the cells producing the spike. And these weren't weak cells—they were robust, immortalized embryonic kidney cells, chosen for their resilience. If these cells showed adverse effects, what is the impact on our more delicate primary cells? The authors themselves caution that proper toxicology studies on normal human cell lines are urgently needed... and are currently unavailable. This isn't conspiracy theory. This is cell biology. The conversation must evolve from if spike protein can travel, to what are the systemic consequences when it does. The call for rigorous, independent safety science has never been louder.

New Research Deep Dive: The "Shedding" Conversation Just Got More Serious A new in-vitro study (using human cells in a lab) on the Pfizer mRNA vaccine has revealed critical findings that can no longer be ignored. Let's break it down. The researchers confirmed two major things: 1️⃣ Spike Protein Production: The cells successfully took up the mRNA and began producing the SARS-CoV-2 spike protein, displaying it on their surface. This was expected. 2️⃣ Spike Protein "Shedding" via Exosomes: Here's the crucial part. The cells didn't just keep the spike protein to themselves. They packaged it into exosomes—tiny extracellular vesicles cells use to communicate—and excreted them into the environment. Why does this matter? This provides a potential mechanistic blueprint for how spike protein could travel systemically throughout the body after vaccination. These spike-laden exosomes can enter the bloodstream and, theoretically, deliver their cargo to distant organs and other cells. But the most alarming part? The authors note a profound lack of safety data. They explicitly state: We have no scientific studies to determine if this exosome-mediated spread of spike protein is toxic to other human cells. Even more concerning, they observed "pathological changes" and toxicity within the cells producing the spike. And these weren't weak cells—they were robust, immortalized embryonic kidney cells, chosen for their resilience. If these cells showed adverse effects, what is the impact on our more delicate primary cells? The authors themselves caution that proper toxicology studies on normal human cell lines are urgently needed... and are currently unavailable. This isn't conspiracy theory. This is cell biology. The conversation must evolve from if spike protein can travel, to what are the systemic consequences when it does. The call for rigorous, independent safety science has never been louder.

Camus

48,219 views • 9 months ago

Reverse aging naturally, the ancient breath that releases stem cells Which also knows as master cells of your body. They are used in regenerative medicine, which means repairing or replacing damaged tissues. Bookmark this video watch later.

Reverse aging naturally, the ancient breath that releases stem cells Which also knows as master cells of your body. They are used in regenerative medicine, which means repairing or replacing damaged tissues. Bookmark this video watch later.

Tehxi

48,379 views • 4 months ago

🧬 Scientists just healed damaged livers with a single injection. Using modified stem cells, researchers repaired severely diseased livers in animal trials, no surgery, no donor, no transplant. 🏥 For thousands on waiting lists, this could change everything. ✨

🧬 Scientists just healed damaged livers with a single injection. Using modified stem cells, researchers repaired severely diseased livers in animal trials, no surgery, no donor, no transplant. 🏥 For thousands on waiting lists, this could change everything. ✨

OMGFacts

26,551 views • 4 months ago

Genomics Expert Kevin McKernan on How He Discovered DNA Contamination in the COVID Vaccines, Which Has Been Replicated in Labs Across the Country "Ask yourselves, do we want to be injecting billions of people with billions of molecules of DNA that could potentially into stem cell genomes or into gametes...When you start getting into stem cells and germ cells, you're in the territory where they put people in jail for doing this. And we've done this not on two CRISPR babies – we've now done this on billions of people who did not consent to this." Kevin McKernan MeehanMD The HighWire Peter A. McCullough, MD, MPH® @P_J_Buckhaults

Genomics Expert Kevin McKernan on How He Discovered DNA Contamination in the COVID Vaccines, Which Has Been Replicated in Labs Across the Country "Ask yourselves, do we want to be injecting billions of people with billions of molecules of DNA that could potentially into stem cell genomes or into gametes...When you start getting into stem cells and germ cells, you're in the territory where they put people in jail for doing this. And we've done this not on two CRISPR babies – we've now done this on billions of people who did not consent to this." Kevin McKernan MeehanMD The HighWire Peter A. McCullough, MD, MPH® @P_J_Buckhaults

Chief Nerd

477,662 views • 3 years ago

🚨ImmunityBio’s Anktiva: A New FDA-Approved Immunotherapy for certain bladder cancer. They are also developing treatments that may reduce the need for strong chemo, for blood cancer, lung cancer, brain cancer, and more. Broader approvals may take time. Someone call the President and fast-track this. Dr. Pat Soon-Shiong leads development beyond typical biotech efforts. Most cancer medicines, like chemotherapy, work by poisoning fast-growing cells to kill the cancer. This also hurts healthy cells, causing side effects like hair loss and weakness. Anktiva is different. It is an immunotherapy that wakes up your body’s own immune cells; natural killer cells and T cells to hunt and destroy cancer cells themselves. It acts like a booster shot for your immune system, using a protein called IL-15 to make these cells multiply and remember how to fight cancer long-term. ImmunityBio is different from most companies because of 3 big unique things: 1. They wake up 3 kinds of fighter cells at the same time: • NK cells (natural killers) • CD8 T cells (main attackers) • CD4 T cells (helpers) These three work together like a basketball team. This makes the body remember the cancer for a long time (maybe years). 2. They have a special cell line called NK-92. → It’s like buying frozen pizza instead of making dough from scratch every time. Doctors can just thaw it and give it to any patient. No need to take cells from the sick kid, customize them, and make them super weak with hospital chemo (that’s what normal CAR-T does). 3. Their medicine Anktiva gives a long, steady boost to the immune cells. Older drugs (like IL-2) gave a short, crazy boost that made people very sick. Anktiva is seems safer, so far. Exciting to follow the development. Interview: Chris Cuomo (NewsNation) — “Killing Cancer”

🚨ImmunityBio’s Anktiva: A New FDA-Approved Immunotherapy for certain bladder cancer. They are also developing treatments that may reduce the need for strong chemo, for blood cancer, lung cancer, brain cancer, and more. Broader approvals may take time. Someone call the President and fast-track this. Dr. Pat Soon-Shiong leads development beyond typical biotech efforts. Most cancer medicines, like chemotherapy, work by poisoning fast-growing cells to kill the cancer. This also hurts healthy cells, causing side effects like hair loss and weakness. Anktiva is different. It is an immunotherapy that wakes up your body’s own immune cells; natural killer cells and T cells to hunt and destroy cancer cells themselves. It acts like a booster shot for your immune system, using a protein called IL-15 to make these cells multiply and remember how to fight cancer long-term. ImmunityBio is different from most companies because of 3 big unique things: 1. They wake up 3 kinds of fighter cells at the same time: • NK cells (natural killers) • CD8 T cells (main attackers) • CD4 T cells (helpers) These three work together like a basketball team. This makes the body remember the cancer for a long time (maybe years). 2. They have a special cell line called NK-92. → It’s like buying frozen pizza instead of making dough from scratch every time. Doctors can just thaw it and give it to any patient. No need to take cells from the sick kid, customize them, and make them super weak with hospital chemo (that’s what normal CAR-T does). 3. Their medicine Anktiva gives a long, steady boost to the immune cells. Older drugs (like IL-2) gave a short, crazy boost that made people very sick. Anktiva is seems safer, so far. Exciting to follow the development. Interview: Chris Cuomo (NewsNation) — “Killing Cancer”

Black Panther Capital

40,249 views • 7 months ago

HOW HONEYBEE VENOM KILLS CANCER CELLS Researchers have discovered that honeybee venom contains a compound called melittin that can kill cancer cells. Melittin disrupts the cancer cell membranes, causing them to break down and die while leaving healthy cells largely unharmed. This promising finding could lead to new, less harmful cancer treatments in the future. Sources: ScienceDaily, Medical News Today, Nature.

HOW HONEYBEE VENOM KILLS CANCER CELLS Researchers have discovered that honeybee venom contains a compound called melittin that can kill cancer cells. Melittin disrupts the cancer cell membranes, causing them to break down and die while leaving healthy cells largely unharmed. This promising finding could lead to new, less harmful cancer treatments in the future. Sources: ScienceDaily, Medical News Today, Nature.

Mario Nawfal

1,335,750 views • 2 years ago

Scientists just figured out how to reverse aging using AI. And this is a massive breakthrough. We can now reprogram any human cell back to age 20. Heart cells, brain cells, skin cells, all reset to their biological prime. And here’s the wildest part…the technology to do this, has already existed since 2012 (it won the Nobel Prize). But the real breakthrough wasn’t possible until this year, when they supercharged it with AI. It’s a wild story. So in 2006, scientists discovered Yamanaka factors. They’re proteins that can basically convert any normal cell into a universal stem cell. Now this was a huge deal, because these stem cells are basically like magic healers. If you have torn muscle tissue, you could inject these stem cells into the area and they will turn into the youthful muscle cells you need. So Yamanaka factors were this insane breakthrough, because they allowed any human to turn any cell you already have into these magic healers. But, there was one big problem… It turns out, the original Yamanaka factors weren’t very good at this stem cell conversion. They could do it, but they just weren’t very reliable. Enter OpenAI...and this is where things get crazy. OpenAI designed a special AI model built specifically to create new proteins. Think of it like ChatGPT but for protein engineering. So they took all the Yamanaka research and asked this new AI to go ham on improving it. And get this… Their version was 50x more effective than the original. They tested it on 50 year old cells and it successfully started repairing 30% of their cells in just 7 days. This is just science fiction…it actually happened. And it sounds crazy, but in a few years, humans will be able to take a shot that will literally reverse the age of their cells.

Scientists just figured out how to reverse aging using AI. And this is a massive breakthrough. We can now reprogram any human cell back to age 20. Heart cells, brain cells, skin cells, all reset to their biological prime. And here’s the wildest part…the technology to do this, has already existed since 2012 (it won the Nobel Prize). But the real breakthrough wasn’t possible until this year, when they supercharged it with AI. It’s a wild story. So in 2006, scientists discovered Yamanaka factors. They’re proteins that can basically convert any normal cell into a universal stem cell. Now this was a huge deal, because these stem cells are basically like magic healers. If you have torn muscle tissue, you could inject these stem cells into the area and they will turn into the youthful muscle cells you need. So Yamanaka factors were this insane breakthrough, because they allowed any human to turn any cell you already have into these magic healers. But, there was one big problem… It turns out, the original Yamanaka factors weren’t very good at this stem cell conversion. They could do it, but they just weren’t very reliable. Enter OpenAI...and this is where things get crazy. OpenAI designed a special AI model built specifically to create new proteins. Think of it like ChatGPT but for protein engineering. So they took all the Yamanaka research and asked this new AI to go ham on improving it. And get this… Their version was 50x more effective than the original. They tested it on 50 year old cells and it successfully started repairing 30% of their cells in just 7 days. This is just science fiction…it actually happened. And it sounds crazy, but in a few years, humans will be able to take a shot that will literally reverse the age of their cells.

Whiplash347

68,643 views • 9 months ago

The $VITASTEM Ignition Sale is now live! The VitaSTEM IP Token aims to reverse aging through rejuvenation of your body's blood-forming stem cells. VitaSTEM is a VitaLabs project that studied 850,000 blood cells from donors aged 23-91 to understand how blood stem cells change over time. They used Aubrai AI to find what breaks - and how to fix it. First time ever: The AI agent gets 20% ownership of the project it helped build. Healthy blood cells = healthy you. VitaSTEM aims to keep them young.

The $VITASTEM Ignition Sale is now live! The VitaSTEM IP Token aims to reverse aging through rejuvenation of your body's blood-forming stem cells. VitaSTEM is a VitaLabs project that studied 850,000 blood cells from donors aged 23-91 to understand how blood stem cells change over time. They used Aubrai AI to find what breaks - and how to fix it. First time ever: The AI agent gets 20% ownership of the project it helped build. Healthy blood cells = healthy you. VitaSTEM aims to keep them young.

VitaDAO 💛

37,052 views • 10 months ago

Tumor cells destroyed by LED light — up to 92% of skin cancer cells killed in 30 minutes while healthy cells stay intact. New lab research (Portugal + Texas, published in ACS Nano): Infrared LEDs heat zinc oxide nanoflakes that selectively target and destroy cancer cells. Artur Pinto (University of Porto): This could be a safe, low-cost alternative to chemotherapy and lasers — and they’re now working toward breast cancer applications. The method exploits the unique heat sensitivity and uptake of cancer cells versus normal cells, achieving high selectivity in early tests. This is early-stage lab work, but the selectivity and simplicity are promising. What do you think — could light-based therapies become a mainstream cancer tool, or is it too early to get excited? Your take 👇 Credit: FOCUS online (YouTube)

Tumor cells destroyed by LED light — up to 92% of skin cancer cells killed in 30 minutes while healthy cells stay intact. New lab research (Portugal + Texas, published in ACS Nano): Infrared LEDs heat zinc oxide nanoflakes that selectively target and destroy cancer cells. Artur Pinto (University of Porto): This could be a safe, low-cost alternative to chemotherapy and lasers — and they’re now working toward breast cancer applications. The method exploits the unique heat sensitivity and uptake of cancer cells versus normal cells, achieving high selectivity in early tests. This is early-stage lab work, but the selectivity and simplicity are promising. What do you think — could light-based therapies become a mainstream cancer tool, or is it too early to get excited? Your take 👇 Credit: FOCUS online (YouTube)

Camus

50,526 views • 5 months ago

🚨 WHY ARE THERE OVER 400 PUBLISHED PAPERS ON IVERMECTIN AND CANCER? Because researchers discovered something unexpected. Ivermectin doesn't just target parasites. According to preclinical research, it appears to interact with cancer cells through multiple biological pathways. One of the most discussed? 📌 Cancer Stem Cells These are the cells believed to survive treatment, remain dormant for years, and potentially contribute to recurrence and spread. According to Dr. William Makis: 💊 Chemotherapy primarily targets rapidly dividing cancer cells. 💊 Ivermectin has been studied for its potential effects on cancer stem cells. That's why some researchers believe the combination deserves attention. But that's only part of the story. Researchers have also investigated ivermectin's potential ability to: ✅ Target cancer stem cells ✅ Influence tumor signaling pathways ✅ Alter cancer cell behavior ✅ Reverse chemotherapy resistance One of the most fascinating findings involves chemotherapy resistance. Over time, some cancer cells develop the ability to push chemotherapy drugs back out of the cell. Researchers have reported that ivermectin may interfere with these resistance mechanisms, potentially making cancer cells susceptible again. And then there's Fenbendazole and Mebendazole. While Ivermectin is being studied for one set of mechanisms, Fenbendazole and Mebendazole appear to work differently. Researchers have investigated their potential ability to: 📌 Block glucose transporters on cancer cells 📌 Reduce the cell's ability to use glucose as fuel 📌 Interfere with pathways associated with tumor growth Think about that. Different compounds. Different mechanisms. The same goal. That's why scientists continue publishing study after study. Not because these compounds are a fad. Because researchers keep uncovering new biological pathways worth investigating. And that's why the conversation around Ivermectin, Fenbendazole, and Mebendazole continues to grow. 💊 If you’re looking into these drugs, check out Ivermectin, Fenbendazole, and Mebendazole from RXMEDS.STORE. #Ivermectin #Fenbendazole #Mebendazole #CancerResearch #CancerStemCells #RepurposedDrugs #CancerBiology #RxMeds

🚨 WHY ARE THERE OVER 400 PUBLISHED PAPERS ON IVERMECTIN AND CANCER? Because researchers discovered something unexpected. Ivermectin doesn't just target parasites. According to preclinical research, it appears to interact with cancer cells through multiple biological pathways. One of the most discussed? 📌 Cancer Stem Cells These are the cells believed to survive treatment, remain dormant for years, and potentially contribute to recurrence and spread. According to Dr. William Makis: 💊 Chemotherapy primarily targets rapidly dividing cancer cells. 💊 Ivermectin has been studied for its potential effects on cancer stem cells. That's why some researchers believe the combination deserves attention. But that's only part of the story. Researchers have also investigated ivermectin's potential ability to: ✅ Target cancer stem cells ✅ Influence tumor signaling pathways ✅ Alter cancer cell behavior ✅ Reverse chemotherapy resistance One of the most fascinating findings involves chemotherapy resistance. Over time, some cancer cells develop the ability to push chemotherapy drugs back out of the cell. Researchers have reported that ivermectin may interfere with these resistance mechanisms, potentially making cancer cells susceptible again. And then there's Fenbendazole and Mebendazole. While Ivermectin is being studied for one set of mechanisms, Fenbendazole and Mebendazole appear to work differently. Researchers have investigated their potential ability to: 📌 Block glucose transporters on cancer cells 📌 Reduce the cell's ability to use glucose as fuel 📌 Interfere with pathways associated with tumor growth Think about that. Different compounds. Different mechanisms. The same goal. That's why scientists continue publishing study after study. Not because these compounds are a fad. Because researchers keep uncovering new biological pathways worth investigating. And that's why the conversation around Ivermectin, Fenbendazole, and Mebendazole continues to grow. 💊 If you’re looking into these drugs, check out Ivermectin, Fenbendazole, and Mebendazole from RXMEDS.STORE. #Ivermectin #Fenbendazole #Mebendazole #CancerResearch #CancerStemCells #RepurposedDrugs #CancerBiology #RxMeds

RXMEDS.STORE

16,612 views • 2 months ago

Bee venom rapidly destroys breast cancer cells in lab tests Researchers at Western Australia University found that melittin (main component of bee venom) wiped out breast cancer cells in a petri dish within 60 minutes—leaving healthy tissue untouched. They then tested it on rats with tumors: Cancer cells destroyed, healthy cells spared. It's incredibly promising, but human trials face major hurdles (allergies to bee venom, regulatory red tape). This could be a game-changer for cancer research. 1:34 clip inside—mind-blowing science.

Bee venom rapidly destroys breast cancer cells in lab tests Researchers at Western Australia University found that melittin (main component of bee venom) wiped out breast cancer cells in a petri dish within 60 minutes—leaving healthy tissue untouched. They then tested it on rats with tumors: Cancer cells destroyed, healthy cells spared. It's incredibly promising, but human trials face major hurdles (allergies to bee venom, regulatory red tape). This could be a game-changer for cancer research. 1:34 clip inside—mind-blowing science.

Camus

95,143 views • 8 months ago

Aaron Siri on How the Polio Vaccine is Made “It is made on immortalized monkey kidney cells … So you take the kidney cells and they modify them to make them basically cancerous, meaning them multiply forever just like cancer cells … After you grow the virus on those kidney cells, you can't completely filter out the cellular substrate. In fact, that's a lot of what's in the vial.”

Aaron Siri on How the Polio Vaccine is Made “It is made on immortalized monkey kidney cells … So you take the kidney cells and they modify them to make them basically cancerous, meaning them multiply forever just like cancer cells … After you grow the virus on those kidney cells, you can't completely filter out the cellular substrate. In fact, that's a lot of what's in the vial.”

Chief Nerd

132,236 views • 11 months ago

About 15% of the world’s population — over a billion people — are affected by neurological disorders. BrainStorm, a San Diego-based startup, is accelerating the development of cures for these conditions using AI-powered computational drug discovery paired with lab experiments using organoids: tiny, 3D bundles of brain cells created from patient-derived stem cells. This hybrid, iterative method, where clinical data and AI models inform one another to accelerate drug development. Learn more ➡️ #NVIDIAInception

About 15% of the world’s population — over a billion people — are affected by neurological disorders. BrainStorm, a San Diego-based startup, is accelerating the development of cures for these conditions using AI-powered computational drug discovery paired with lab experiments using organoids: tiny, 3D bundles of brain cells created from patient-derived stem cells. This hybrid, iterative method, where clinical data and AI models inform one another to accelerate drug development. Learn more ➡️ #NVIDIAInception

NVIDIA AI Developer

26,637 views • 1 year ago

🚨Here's what a lot of people misunderstand about cancer treatment, says drpaulmarik: "Cancer is not homogeneous. The somatic mutation theory—which is the current theory in which treatment is based—posits that you have a mutation in a single cell, and that gives rise to a whole population of cells that look the same and have the same mutation. But the Cancer Genome Atlas has shown that that theory is completely wrong. The cancer cells are very heterogeneous, so they're made up of very different populations of cells with different mutations, and one of the populations is the cancer stem cell. It's a sub-population of the cancer. These are generally slow-growing, but they're distinct in that they have the ability to divide indefinitely and grow indefinitely, and can change their characteristics. Basically, if you get rid of the fast-dividing cells, which is the cancer, you're left with the stem cells, which then become the roots, which grow back to form the tumor" sometimes years later. Conventional chemotherapy gets rid of the fast-dividing regular cancer cells but *NOT* the stem cells. So the key question is: how do you get rid of the stem cells? “There are a number of repurposed drugs that do it, and this has been well-established in scientific medical literature. One of the most effective treatments to knock out the stem cell is the famous horse deworming medicine," says drpaulmarik. Yes, ivermectin. Independent Medical Alliance

🚨Here's what a lot of people misunderstand about cancer treatment, says drpaulmarik: "Cancer is not homogeneous. The somatic mutation theory—which is the current theory in which treatment is based—posits that you have a mutation in a single cell, and that gives rise to a whole population of cells that look the same and have the same mutation. But the Cancer Genome Atlas has shown that that theory is completely wrong. The cancer cells are very heterogeneous, so they're made up of very different populations of cells with different mutations, and one of the populations is the cancer stem cell. It's a sub-population of the cancer. These are generally slow-growing, but they're distinct in that they have the ability to divide indefinitely and grow indefinitely, and can change their characteristics. Basically, if you get rid of the fast-dividing cells, which is the cancer, you're left with the stem cells, which then become the roots, which grow back to form the tumor" sometimes years later. Conventional chemotherapy gets rid of the fast-dividing regular cancer cells but NOT the stem cells. So the key question is: how do you get rid of the stem cells? “There are a number of repurposed drugs that do it, and this has been well-established in scientific medical literature. One of the most effective treatments to knock out the stem cell is the famous horse deworming medicine," says drpaulmarik. Yes, ivermectin. Independent Medical Alliance

Jan Jekielek

96,002 views • 1 year ago